Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
24.52
-0.08 (-0.33%)
At close: Mar 24, 2026, 4:00 PM EDT
24.49
-0.03 (-0.13%)
After-hours: Mar 24, 2026, 5:46 PM EDT
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.45 billion as of March 24, 2026. Its market cap has increased by 45.45% in one year.
Market Cap
1.45B
Enterprise Value
1.19B
1-Year Change
45.45%
Ranking
Category
Stock Price
$24.52
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.45B, an increase of 812.10%. That is a compound annual growth rate of 57.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 1.46B | 26.09% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | 159.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 1.53B |
| Immunocore Holdings | 1.52B |
| Intellia Therapeutics | 1.51B |
| Novavax | 1.51B |
| Iovance Biotherapeutics | 1.49B |
| Nuvation Bio | 1.49B |
| Nurix Therapeutics | 1.49B |
| Damora Therapeutics | 1.44B |